Antimicrobial-impregnated central venous catheters for prevention of catheter-related bloodstream infection in newborn infants

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 5, 2014, Pages

  Balain, Munisha ^a   Oddie, Sam ^a   Mcguire, William ^b  

^a BRADFORD ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ARTICLE; CATHETER INFECTION; COMPARATIVE EFFECTIVENESS; DEVICE REMOVAL; HUMAN; LENGTH OF STAY; LUNG DYSPLASIA; META ANALYSIS (TOPIC); NECROTIZING ENTEROCOLITIS; NEWBORN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROLENTAL FIBROPLASIA; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC);

EID: 85041720329     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD011078     Document Type: Article

References (62)

1. Adams-Chapman I, Stoll BJ. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Current Opinion in Infectious Diseases 2006;19(3):290-7.
2. Alonso-Echanove J, Edwards JR, Richards MJ, Brennan P, Venezia RA, Keen J, et al. Effect of nurse staffing and antimicrobial-impregnated central venous catheters on the risk for bloodstream infections in intensive care units. Infection Control and Hospital Epidemiology 2003;24(12):916-25.
3. Aslam S, Darouiche RO. Prolonged bacterial exposure to minocycline/rifampicin-impregnated vascular catheters does not affect antimicrobial activity of catheters. The Journal of Antimicrobial Chemotherapy 2007;60(1):148-51. [PUBMED: 17525051]
4. Bassler D, Stoll BJ, Schmidt B, Asztalos EV, Roberts RS, Robertson CM, et al. Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection. Pediatrics 2009;123(1):313-8.
5. Benjamin DK Jr, Miller W, Garges H, Benjamin DK, McKinney RE Jr, Cotton M, et al.Bacteremia, central catheters, and neonates: when to pull the line. Pediatrics 2001;107(6):1272-6. [PUBMED: 11389242]
6. Borghesi A, Stronati M. Strategies for the prevention of hospital-acquired infections in the neonatal intensive care unit. Journal of Hospital Infection 2008;68(4):293-300.
7. Cartwright DW. Central venous lines in neonates: a study of 2186 catheters. Archives of Disease in Childhood. Fetal and Neonatal Edition 2004;89(6):F504-8.
8. Casey AL, Mermel LA, Nightingale P, Elliott TS. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. The Lancet Infectious Diseases 2008;8(12):763-76.
9. Chapman RL, Faix RG. Persistent bacteremia and outcome in late onset infection among infants in a neonatal intensive care unit. Pediatric Infectious Disease Journal 2003;22(1):17-21.
10. Cicalini S, Palmieri F, Petrosillo N. Clinical review: new technologies for prevention of intravascular catheter-related infections. Critical Care 2004;8(3):157-62.
11. de Brito CS, de Brito DV, Abdallah VO, Gontijo Filho PP. Occurrence of bloodstream infection with different types of central catheter in critically neonates. Journal of Infection 2010;60(2):128-32.
12. Eggimann P, Pittet D. Pathophysiology and prevention of intravascular catheter-related infection [Physiopathologie et prevention des infections liees aux acces vasculaires]. Medecine et Maladies Infectieuses 2003;33(11):554-63.
13. Garland JS, Alex CP, Sevallius JM, Murphy DM, Good MJ, Volberding AM, et al. Cohort study of the pathogenesis and molecular epidemiology of catheter-related bloodstream infection in neonates with peripherally inserted central venous catheters. Infection Control and Hospital Epidemiology 2008;29(3):243-9.
14. Gilbert RE, Harden M. Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review. Current Opinion in Infectious Diseases 2008;21(3):235-45. [DOI: 10]
15. Gordon A, Isaacs D. Late onset neonatal Gram-negative bacillary infection in Australia and New Zealand: 1992-2002. Pediatric Infectious Disease Journal 2006;25(1):25-9.
16. Halton KA, Cook DA, Whitby M, Paterson DL, Graves N. Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision. Critical Care 2009;13(2):R35.
17. Hermans D, Talbotec C, Lacaille F, Goulet O, Ricour C, Colomb V. Early central catheter infections may contribute to hepatic fibrosis in children receiving long-term parenteral nutrition. Journal of Pediatric Gastroenterology and Nutrition 2007;44(4):459-63.
18. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
19. Hoang V, Sills J, Chandler M, Busalani E, Clifton-Koeppel R, Modanlou HD. Percutaneously inserted central catheter for total parenteral nutrition in neonates: complication rates related to upper versus lower extremity insertion. Pediatrics 2008;121(5):e1152-9.
20. Hockenhull JC, Dwan K, Boland A, Smith G, Bagust A, Dündar Y, et al. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. Health Technology Assessment 2008;12(12):iii-iv, xi-xii, 1-154.
21. Isaacs D, The Australasian Study Group For Neonatal Infections. A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units. Archives of Disease in Childhood. Fetal and Neonatal Edition 2003;88(2):F89-93.
22. Isaacs D, Fraser S, Hogg G, Li HY. Staphylococcus aureus infections in Australasian neonatal nurseries. Archives of Disease in Childhood. Fetal and Neonatal Edition 2004;89(4):F331-5.
23. Kaplan HC, Lannon C, Walsh MC, Donovan EF, Ohio Perinatal Quality Collaborative. Ohio statewide quality-improvement collaborative to reduce late onset sepsis in preterm infants. Pediatrics 2011;127(3):427-35.
24. Lahra MM, Beeby PJ, Jeffery HE. Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study. Pediatrics 2009;123(5):1314-9.
25. Lambert A, Lemarignier-Nueffer C, Iooss P, Roncalez D. Anti-infective-treated central venous catheters clinical effectiveness and safety [Evaluation de l'interet clinique et de la tolerance des catheters veineux centraux impregnes d'antimicrobiens]. Journal de Pharmacie Clinique 2012;31(2):73-87.
26. Machado JD, Suen VM, Figueiredo JF, Marchini JS. Biofilms, infection, and parenteral nutrition therapy. Journal of Parenteral and Enteral Nutrition 2009;33(4):397-403.
27. Mahieu LM, De Dooy JJ, De Muynck AO, Van Melckebeke G, Ieven MM, Van Reempts PJ. Microbiology and risk factors for catheter exit-site and hub colonization in neonatal intensive care unit patients. Infection Control and Hospital Epidemiology 2001;22(6):357-62.
28. Mahieu LM, Buitenweg N, Beutels P, De Dooy JJ. Additional hospital stay and charges due to hospital-acquired infections in a neonatal intensive care unit. The Journal of Hospital Infection 2001;47(3):223-9.
29. Mahieu LM, De Muynck AO, Ieven MM, De Dooy JJ, Goossens HJ, Van Reempts PJ. Risk factors for central vascular catheter-associated bloodstream infections among patients in a neonatal intensive care unit. The Journal of Hospital Infection 2001;48(2):108-16. [PUBMED: 11428877]
30. Mahieu LM, De Dooy JJ, Lenaerts AE, Ieven MM, De Muynck AO. Catheter manipulations and the risk of catheter-associated bloodstream infection in neonatal intensive care unit patients. The Journal of Hospital Infection 2001;48(1):20-6. [PUBMED: 11358467]
31. Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics 2002;109(1):34-9.
32. Miller MR, Griswold M, Harris JM 2nd, Yenokyan G, Huskins WC, Moss M, et al. Decreasing PICU catheter-associated bloodstream infections: NACHRI's quality transformation efforts. Pediatrics 2010;125(2):206-13.
33. Munson EL, Heard SO, Doern GV. In vitro exposure of bacteria to antimicrobial impregnated-central venous catheters does not directly lead to the emergence of antimicrobial resistance. Chest 2004;126(5):1628-35. [PUBMED: 15539737]
34. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter-related infections. Infection Control and Hospital Epidemiology 2002;23(15):759-69.
35. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. American Journal of Infection Control 2011;39(4 Suppl 1):S1-34.
36. Ohki Y, Yoshizawa Y, Watanabe M, Kuwashima M, Morikawa A. Complications of percutaneously inserted central venous catheters in Japanese neonates. Pediatrics International 2008;50(5):636-9.
37. Olsen AL, Reinholdt J, Jensen AM, Andersen LP, Jensen ET. Nosocomial infection in a Danish Neonatal Intensive Care Unit: a prospective study. Acta Paediatrica 2009;98(8):1294-9.
38. Payne NR, Carpenter JH, Badger GJ, Horbar JD, Rogowski J. Marginal increase in cost and excess length of stay associated with nosocomial bloodstream infections in surviving very low birth weight infants. Pediatrics 2004;114(2):348-55.
39. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. New England Journal of Medicine 2006;355(26):2725-32.
40. Ramirez de Arellano E, Pascual A, Martinez-Martinez L, Perea EJ. Activity of eight antibacterial agents on staphylococcus epidermidis attached to Teflon catheters. Journal of Medical Microbiology 1994;40(1):43-7.
41. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
42. Saint S, Veenstra DL, Lipsky BA. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful?. Infection Control and Hospital Epidemiology 2000;21(6):375-80.
43. Salzman MB, Rubin LG. Intravenous catheter-related infections. Advances in Pediatric Infectious Diseases 1995;10:337-68. [PUBMED: 7718211]
44. Sampath LA, Tambe SM, Modak SM. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infection Control and Hospital Epidemiology 2001;22(10):640-6. [PUBMED: 11776351]
45. Sannoh S, Clones B, Munoz J, Montecalvo M, Parvez B. A multimodal approach to central venous catheter hub care can decrease catheter-related bloodstream infection. American Journal of Infection Control 2010;38(6):424-9.
46. Schelonka RL, Scruggs S, Nichols K, Dimmitt RA, Carlo WA. Sustained reductions in neonatal nosocomial infection rates following a comprehensive infection control intervention. Journal of Perinatology 2006;26(3):176-9.
47. Schulman J, Stricof R, Stevens TP, Horgan M, Gase K, Holzman IR, et al. Statewide NICU central-line-associated bloodstream infection rates decline after bundles and checklists. Pediatrics 2011;127(3):436-44.
48. Shah DK, Doyle LW, Anderson PJ, Bear M, Daley AJ, Hunt RW, et al. Adverse neurodevelopment in preterm infants with postnatal sepsis or necrotizing enterocolitis is mediated by white matter abnormalities on magnetic resonance imaging at term. The Journal of Pediatrics 2008;153(2):170-5.
49. Shorr AF, Humphreys CW, Helman DL. New choices for central venous catheters: potential financial implications. Chest 2003;124(1):275-84.
50. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. The Lancet 2001;358(9276):135-8.
51. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al.Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110(2 Pt 1):285-91.
52. Stoll BJ, Hansen N, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, at al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004;292(19):2357-65.
53. Tambe SM, Sampath L, Modak SM. In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. The Journal of antimicrobial chemotherapy 2001;47(5):589-98. [PUBMED: 11328769]
54. Thornburg CD, Smith PB, Smithwick ML, Cotten CM, Benjamin DK Jr. Association between thrombosis and bloodstream infection in neonates with peripherally inserted catheters. Thrombosis Research 2008;122(6):782-5. [PUBMED: 17997477]
55. Trotter CW. Percutaneous central venous catheter-related sepsis in the neonate: an analysis of the literature from 1990 to 1994. Neonatal Network 1996;15(3):15-28.
56. Trotter CW. Percutaneous central venous catheters in neonates: a descriptive analysis and evaluation of predictors for sepsis. The Journal of Perinatal and Neonatal Nursing 1996;10(2):56-71.
57. van der Zwet WC, Kaiser AM, van Elburg RM, Berkhof J, Fetter WP, Parlevliet GA, et al. Nosocomial infections in a Dutch neonatal intensive care unit: surveillance study with definitions for infection specifically adapted for neonates. Journal of Hospital Infection 2005;61(4):300-11.
58. Vanholder R, Canaud B, Fluck R, Jadoul M, Labriola L, Marti-Monros, A, et al.Catheter-related blood stream infections (CRBSI): a European view. Nephrology, Dialysis, Transplantation 2010;25(6):1753-6.
59. Walz JM, Memtsoudis SG, Heard SO. Prevention of central venous catheter bloodstream infections. Journal of Intensive Care Medicine 2010;25(3):131-8.
60. Wirtschafter DD, Pettit J, Kurtin P, Dalsey M, Chance K, Morrow HW, et al. A state wide quality improvement collaborative to reduce neonatal central line-associated blood stream infections. Journal of Perinatology 2010;30(3):170-81.
61. Wong J, Dow K, Shah PS, Andrews W, Lee S. Percutaneously placed central venous catheter-related sepsis in Canadian neonatal intensive care units. American Journal of Perinatology 2012;29(8):629-34. [PUBMED: 22566117]
62. Yébenes JC, Vidaur L, Serra-Prat M, Sirvent JM, Batlle J, Motje M, et al. Prevention of catheter related blood stream infection in critically ill patients using a disinfectable, needle free connector: a randomised controlled trial. American Journal of Infection Control 2004;32(5):291-5.